Advertisement

Topics

Asymchem Passes FDA Inspection at API Mfg. Site

04:25 EDT 14 Sep 2018 | Contract Pharma

Reports successful FDA inspection of Tianjin 2 development and commercial manufacturing facility with no Form 483 issued

Original Article: Asymchem Passes FDA Inspection at API Mfg. Site

NEXT ARTICLE

More From BioPortfolio on "Asymchem Passes FDA Inspection at API Mfg. Site"

Advertisement
Quick Search
Advertisement
Advertisement